In chronic myeloid leukemia (CML), CXCL12 is secreted by MSCs, reducing caspase 3 activity in a CXCR4-dependent manner and attenuating cell death induced by imatinib [133]. This evidence concerns the gene CASP3 and chronic myelogenous leukemia, BCR-ABL1 positive.